Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 101

 

Home  | About Us | Editors | Search | Ahead Of Print | Current Issue | Archives | Submit Article | Instructions | Subscribe | Contacts | Login 
     
EDITORIAL
Year : 2021  |  Volume : 11  |  Issue : 3  |  Page : 109-111

What's new in critical illness and injury science? An evidence-based analysis of the impact of Janus Kinase inhibitors on 28-day mortality in patients admitted with COVID-19


1 Department of Emergency Medicine, Alton Memorial Hospital, Alton, IL, USA
2 Department of Internal Medicine, Rhode Island Hospital and Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA

Correspondence Address:
Dr. Andrew C Miller
Department of Emergency Medicine, Alton Memorial Hospital, One Memorial Drive, Alton, IL 62002
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijciis.ijciis_80_21

Rights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed722    
    Printed40    
    Emailed0    
    PDF Downloaded38    
    Comments [Add]    

Recommend this journal